Your browser doesn't support javascript.
loading
Factors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized Dosing.
Sundell, Jesper; Wijk, Marie; Bienvenu, Emile; Äbelö, Angela; Hoffmann, Kurt-Jürgen; Ashton, Michael.
Afiliación
  • Sundell J; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Wijk M; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Bienvenu E; Department of Pharmacy, School of Medicine and Pharmacy, University of Rwanda, Kigali, Rwanda.
  • Äbelö A; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Hoffmann KJ; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Ashton M; Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Antimicrob Agents Chemother ; 65(7): e0004621, 2021 06 17.
Article en En | MEDLINE | ID: mdl-33875424

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Coinfección Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Coinfección Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2021 Tipo del documento: Article País de afiliación: Suecia